Alessio Raggi

Dr. Alessio Raggi

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
GPGabriele Polonara
Gabriele Polonara
Denis AiudiDenis Aiudi
Denis Aiudi
AIAlessio Iacoangeli
Alessio Iacoangeli
ARAlessio Raggi
Alessio Raggi
Matteo Maria OttavianiMatteo Maria Ottaviani
Matteo Maria Ottaviani
MDMauro Dobran
Mauro Dobran
Background: Glioblastoma (GBM) is the most common and aggressive primary brain tumor in adults; despite advances in the understanding of GBM pathogenesis, significant achievements in treating this disease are still lacking. The aim of this study was to evaluate the prognostic significance of the extent of surgical resection (EOR), beyond the neoplastic mass, on the overall survival (OS). Methods: A retrospective review of a single-institution glioblastoma patient database (January 2012–September 2021) was undertaken. The series is composed of 64 patients who underwent surgery at the University Department of Neurosurgery of Ancona; the series was divided into four groups based on the amount of tumor mass excision with the fluid-attenuated inversion recovery (FLAIR) abnormalities (SUPr-supratotal resection, GTR-gross total resection, STR-subtotal resection, BIOPSY). The hypothesis was that the maximal resection of FLAIR abnormalities may improve the overall survival compared to the resection of the visible T1 contrast-enhanced neoplastic area only. Results: In the univariate analysis, SUPr and GTR are correlated with the overall survival (p = 0.001); the percentage of total neoplastic removal threshold conditioning outcome was 90% (p = 0.027). These results were confirmed by the multivariate analysis. Conclusions: Maximal surgical resection, when feasible, involving areas of FLAIR abnormalities represents an advantageous approach for the OS in GBM patients.

17 November 2023 in Surgical Neurology International
Verified
Journal Article
Open access
MDMauro Dobran
Mauro Dobran
ARALESSANDRO DI RIENZO
ALESSANDRO DI RIENZO
ECErika Carrassi
Erika Carrassi
Denis AiudiDenis Aiudi
Denis Aiudi
ARAlessio Raggi
Alessio Raggi
MIMaurizio Iacoangeli
Maurizio Iacoangeli
Background: Decompressive craniectomy (DC) is still controversial in neurosurgery. According to the most recent trials, DC seems to increase survival in case of refractory intracranial pressure. On the other hand, the risk of postsurgical poor outcomes remain high. The present study aimed to evaluate a series of preoperative factors potentially impacting on long-term follow-up of traumatic brain injury (TBI) patients treated with DC. Methods: We analyzed the first follow-up year of a series of 75 TBI patients treated with DC at our department in five years (2015–2019). Demographic, clinical, and radiological parameters were retrospectively collected from clinical records. Blood examinations were analyzed to calculate the preoperative neutrophil-to-lymphocyte ratio (NLR). Disability rating scale (DRS) was used to classify patients’ outcomes (good outcome [G.O.] if DRS ≤11 and poor outcome [P.O.] if DRS ≥12) at 6 and 12 months. Results: At six months follow-up, 25 out of 75 patients had DRS ≤11, while at 12 months, 30 out of 75 patients were included in the G.O. group . Admission Glasgow Coma Scale (GCS) >8 was significantly associated with six months G.O. Increased NLR values and the interval between DC and cranioplasty >3 months were significantly correlated to a P.O. at 6- and 12-month follow-up. Conclusion: Since DC still represents a controversial therapeutic strategy, selecting parameters to help stratify TBI patients’ potential outcomes is paramount. GCS at admission, the interval between DC and cranioplasty, and preoperative NLR values seem to correlate with the long-term outcome.

22 November 2024 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
Denis AiudiDenis Aiudi
Denis Aiudi
AIAlessio Iacoangeli
Alessio Iacoangeli
AMAndrea Mattioli
Andrea Mattioli
ARAlessio Raggi
Alessio Raggi
MDMauro Dobran
Mauro Dobran
MGMaurizio Gladi
Maurizio Gladi
Background/Objectives: Indocyanine green video angiography, integrated into the operative microscope, is frequently used in cerebrovascular surgery. This technology is often preferred, for cost or availability, to Doppler or intraoperative DSA (digital subtraction angiography). With the same assumption it was possible, in our preliminary experience, to partially vicariate the aforementioned devices using the SPY mode of the Stryker endoscope; it allowed the visualization of fluorescence in high definition. Methods: A retrospective analysis was conducted on a series of five patients suffering from cerebral aneurysm or AVM (arteriovenous malformation) who underwent, during the last year, surgical treatment with the aid of the microscope supported by the Stryker endoscope in the SPY mode for the visualization of the fluorescence emitted by indocyanine green. Results: All aneurysms were completely excluded from the cerebrovascular circulation in the absence of residues in the collar and occlusion of adjacent vessels; the complete removal of the nidus in all the AVMs was achieved with no residues. Conclusions: The intraoperative use of indocyanine green was a safe, rapid, and effective technique within a preliminary case study of “regular—not giant” aneurysms and superficially located AVM. The endoscopic technique in the SPY mode has allowed to partially vicariate the use of Doppler, intraoperative angiography, and integrated microscope video angiography. For these purposes, we propose, in selected cases, the support of the endoscope in the SPY mode during the microsurgical procedure in order to visualize the green fluorescence of indocyanine.

23 October 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
Denis AiudiDenis Aiudi
Denis Aiudi
AIAlessio Iacoangeli
Alessio Iacoangeli
AMAndrea Mattioli
Andrea Mattioli
ARAlessio Raggi
Alessio Raggi
MDMauro Dobran
Mauro Dobran
MGMaurizio Gladi
Maurizio Gladi
Background/Objectives: Indocyanine green videoangiography, integrated in the operative microscope, is frequently used in cerebrovascular surgery; it is believed to be a simple and reliable method for capturing high-resolution images in a real-time setting. This technology is often preferred, for cost or availability, to Doppler or intraoperative angiography DSA (Digital substraction angiography): with the same assumption it was possible, in our preliminary experience, to partially vicariate the aforementioned devices using the SPY mode of the Stryker endoscope; it allowed the visualization of fluorescence in high definition.; Methods: A retrospective analysis was conducted on a series of 5 patients suffering from cerebral aneurysm or AVM who underwent, during the last year at our institution, surgical treatment with the aid of the microscope supported by the Stryker endoscope in SPY mode for the visualization of fluorescence emitted by indocyanine green; Results: The intraoperative use of indocyanine green was a safe, rapid and effective technique within a preliminary case study of "regular - not giant" aneurysms and AVM located superficially in the cerebral parenchyma. The endoscopic technique in SPY mode has allowed to partially vicariate, in selected cases, the use of Doppler, intraoperative angiography and integrated microscope video angiography; Conclusions: the main purpose of aneurysm surgery is to completely exclude them from the cerebral vascular circulation in the absence of residues in the collar and occlusion of adjacent vessels; similarly, in AVM surgery the goal is the early identification of the nidus and to avoid residues within it given the high risk of new rupture. For these purposes, we propose, in selected cases and keeping in mind the limitations of the technique already described in the literature, the support of the endoscope in SPY mode during the microsurgical procedure in order to visualize the green fluorescence of indocyanine.